DRUG MODALITIES NCE ADC ONT CELL THERAPY GENE THERAPY PROTAC LNP- mRNA EXOSOME
AI-Powered Drug Development Platform

Precision PK/PD
Modeling &
ADME Intelligence

Accelerate your drug development pipeline with cutting-edge AI-driven pharmacokinetic modeling, ADME prediction, and toxicity assessment services tailored for modern pharmaceutical research.

98%
Prediction Accuracy
10×
Faster Analysis
500+
Compounds Analyzed

End-to-End Drug
Development Solutions

01 — PK/PD MODELING

PK/PD Modeling & Simulation

Comprehensive pharmacokinetic and pharmacodynamic modeling using AI-enhanced NONMEM and population-based approaches to characterize drug behavior in biological systems.

Population PK NONMEM Monolix M&S
02 — ADME PREDICTION

ADME Prediction

AI-driven in silico prediction of absorption, distribution, metabolism, and excretion properties to accelerate early drug discovery and reduce experimental costs.

Absorption BBB Penetration CYP450 Bioavailability
03 — TOXICITY ASSESSMENT

Toxicity Assessment

Multi-endpoint toxicity prediction using deep learning models trained on large chemical databases, covering hepatotoxicity, cardiotoxicity, and regulatory-relevant endpoints.

hERG DILI Ames Test ICH Guidelines
04 — CLINICAL TRIAL SUPPORT

Clinical Trial Design Support

Model-informed drug development (MIDD) strategies for dose selection, trial design optimization, and regulatory submission support using quantitative systems pharmacology.

MIDD Dose Optimization FDA/EMA QSP
05 — BIOEQUIVALENCE

Bioequivalence Analysis

Rigorous statistical analysis and modeling for generic drug bioequivalence studies, NDA/ANDA submissions, and comparative pharmacokinetic assessments.

BE Studies NCA ANDA Statistics
06 — REGULATORY CONSULTING

Regulatory Consulting

Expert guidance on regulatory strategies, IND/NDA preparation, and interaction with FDA, EMA, and global health authorities for pharmacokinetic and clinical pharmacology sections.

IND/NDA FDA Meetings EMA ICH

AI-Driven Analytical
Pipeline

01

Data Ingestion & Curation

Automated collection and quality control of clinical, preclinical, and in vitro data with intelligent anomaly detection.

02

AI Model Selection

Machine learning algorithms identify optimal PK/PD model structures from thousands of candidate models in seconds.

03

Parameter Estimation

Bayesian and frequentist estimation frameworks with automated covariate selection and model diagnostics.

04

Simulation & Prediction

Monte Carlo simulations for virtual patient populations and clinical trial outcome prediction.

05

Report Generation

Automated regulatory-ready reports with interactive visualizations and full audit trails.

DATA INGESTION 01 AI/ML MODEL SELECT 02 ADME PREDICT TOX ASSESS PK/PD NONMEM · MONOLIX 03 SIM MONTE CARLO VPC VALIDATION OUTPUT REPORT · PDF 04 Pharmconsulting LLC

Powered by Industry-
Leading Tools

NONMEM

Population PK/PD estimation

Monolix

SAEM algorithm modeling

Phoenix WinNonlin

NCA & regulatory analysis

Pirana

NONMEM project management

R / Xpose4

Diagnostics & visualization

Python / TF

Deep learning toxicity models

SimCYP

PBPK & DDI prediction

GastroPlus

Absorption & formulation

Bridging Science &
Innovation

Pharmconsulting LLC is a specialized pharmaceutical consulting firm dedicated to accelerating drug development through the intelligent application of AI and advanced modeling techniques.

Our team of experienced pharmacometricians, computational scientists, and regulatory experts brings decades of combined expertise to every project — from early discovery through post-marketing commitments.

FDA & EMA regulatory experience
Validated AI modeling platforms
Rapid turnaround — 48hr preliminary results
Full GLP/GCP compliance
Confidential & secure data handling
15+
Years Experience
50+
Client Projects
30+
FDA Submissions
8+
Expert Scientists

Start Your Project
Today

Tell us about your drug development challenge and we'll connect you with the right expert within 24 hours.